The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 351-357

  Sun, Kai ^a   Xue, Hong ^a   Wang, Hui ^a   Wang, Qiang ^a   Zuo, Xiang Rong ^a   Xie, Wei Ping ^a   Wang, Hong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Proliferation; Pulmonary arterial hypertension; Pulmonary arterial smooth muscle cell; Ribosomal protein L22

Indexed keywords

CYCLIN D1; ET 1 PROTEIN; PEPTIDES AND PROTEINS; RIBOSOMAL PROTEIN L22; RIBOSOME PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN PULMONARY ARTERIAL SMOOTH MUSCLE CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; ENDOTHELIN-1; GENE EXPRESSION; HUMANS; MYOCYTES, SMOOTH MUSCLE; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ARTERY; RIBOSOMAL PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84863550551     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.992     Document Type: Article

References (34)

1. Galiè N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 30: 2493-2537, 2009.
2. McLaughlin VV, Archer SL, Badesch DB, et al: ACCF/AHA 2009 expert consensus document on pulmonary hypertension. Circulation 119: 2250-2294, 2009.
3. Stewart S and Rassl D: Advances in the understanding and classification of pulmonary hypertension. Histopathology 54: 104-116, 2009.
4. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 (Suppl 12): S13-S24, 2004.
5. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ and Yuan JX: Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 68: 75-103, 2004.
6. Gurbanov E and Shiliang X: The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg 30: 499-507, 2006.
7. Archer SL, Weir EK and Wilkins MR: Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121: 2045-2066, 2010.
8. Morrell NW, Adnot S, Archer SL, et al: Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54 (Suppl 1): S20-S31, 2009.
9. Uechi T, Tanaka T and Kenmochi N: A complete map of the human ribosomal protein genes: assignment of 80 genes to the cytogenetic map and implications for human disorders. Genomics 72: 223-230, 2001.
10. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA and Xiong Y: Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912, 2003.
11. Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Schneider H, Darras N, Hasman C, Sieff CA, Newburger PE, et al: Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83: 769-780, 2008.
12. Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB and Oren M: Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 32: 180-189, 2008.
13. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA, Gerhardt B, Hardy RR, Oravecz T and Wiest DL: Ablation of ribosomal protein L22 selectively impairs αβ T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759-772, 2007.
14. Pan Z, Huang J, Cui W, Long C, Zhang Y and Wang H: Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim. J Cardiovasc Pharmacol 56: 215-228, 2010.
15. Wang H, Tang Y and Zhang YL: Hypoxic pulmonary hypertension (HPH) and iptakalim, a novel ATP-sensitive potassium channel opener targeting smaller arteries in hypertension. Cardiovasc Drug Rev 23: 293-316, 2005.
16. Yang MX, Liu ZX, Zhang S, Jing Y, Zhang SJ, Xie WP, Ma L, Zhu CL and Wang H: Proteomic analysis of the effect of iptakalim on human pulmonary arterial smooth muscle cell proliferation. Acta Pharmacol Sin 30: 175-183, 2009.
17. ATP channel. Vascul Pharmacol 48: 92-99, 2008.
18. Sakao S, Tatsumi K and Voelkel NF: Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res 10: 95-103, 2009.
19. Maclean MR and Dempsie Y: The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol 661: 309-322, 2010.
20. Burg ED, Remillard CV and Yuan JX: Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153 (Suppl 1): S99-S111, 2008.
21. Zhao YY and Malik AB: A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation. Trends Cardiovasc Med 19: 238-242, 2009.
22. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, McMahon G, Waltenberger J, Voelkel NF and Tuder RM: Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell deathdependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15: 427-438, 2001.
23. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W and Grimminger F: Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811-2821, 2005.
24. Lagna G, Nguyen PH, Ni W and Hata A: BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 291: L1059-L1067, 2006.
25. ATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. Eur J Pharmacol 511: 81-87, 2005.
26. Rohit B, Rubin MT and Paul MH: Endothelial dysfunction in pulmonary hypertension. Circulation 109: 159-165, 2004.
27. B receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165: 398-405, 2002.
28. Tronic E and Webb DJ: Endothelium-derived endothelin-1. Pflug Arch Eur J Phy 459: 951-958, 2010.
29. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F and Yazaki Y: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249-252, 1988.
30. Jankov RP, Kantores C, Belcastro R, Yi M and Tanswell AK: Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat. Pediatr Res 60: 245-251, 2006.
31. Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ and Bessler M: The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 14: 1918-1929, 2008.
32. Hernandez-Verdun D: Assembly and disassembly of the nucleolus during the cell cycle. Nucleus 2: 189-194, 2011.
33. Stacey DW: Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 15: 158-163, 2003.
34. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ, Zhang W, Fuchs H, de Angelis MH, Myers RM, et al: Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40: 963-970, 2008.